Interestingly, the analysis of the TCGA dataset from 335 prostate cancer patients [27] demonstrated that this SNP appears to have no effect on most of these genes except for SLC22A1 and SLC22A3 (Supplementary Figure S2). Here, SLC22A1 is linked to prostate cancer.